Impact of the Timing of Cutaneous Immune-Related Adverse Events on Survival Outcomes in Patients With Cancer Treated With Immune Checkpoint Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Timing of cutaneous immune-related adverse events impacts survival in cancer patients treated with immune-checkpoint inhibitors: A multi-institutional cohort study
J Am Acad Dermatol 2024 Jan 28;[EPub Ahead of Print], H Rashdan, S Zhang, G Wan, N Nguyen, K Roster, A Rajeh, K Tang, W Chen, C Moseley, S Chen, N LeBoeuf, YR SemenovFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.